| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―19 |
Postpandemic adjuvants to tailor vaccine-induced immunity |
Divya Sinha, Garance Coquant, Xinchen Yuan, Stéphane Paul, Stéphanie Longet |
| 2 |
[GO] |
2025―Mar―27 |
Deciphering SARS-CoV-2 evolution under antibody immune pressure |
Fanchong Jian, Yunlong Cao |
| 3 |
[GO] |
2024―Nov―22 |
SARS-CoV-2 reprograms murine alveolar macrophages to dampen flu |
Alexandra Tabachnikova, Akiko Iwasaki |
| 4 |
[GO] |
2024―Nov―18 |
The immune-endocrine interplay in sex differential responses to viral infection and COVID-19 |
Valentino D’Onofrio, Rafick Pierre Sékaly |
| 5 |
[GO] |
2024―Sep―26 |
Unmasking SARS-CoV-2’s coagulation conspiracy: the role of Spike |
Tom Aschman, Helena Radbruch |
| 6 |
[GO] |
2024―Sep―25 |
COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzle |
Elena Magrini, Cecilia Garlanda |
| 7 |
[GO] |
2024―Jul―20 |
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies |
Arman Izadi, Pontus Nordenfelt |
| 8 |
[GO] |
2024―Jun―17 |
SARS-CoV-2 humoral immunity in people living with HIV-1 |
Boitumelo M. Motsoeneng, Jinal N. Bhiman, Simone I. Richardson, Penny L. Moore |
| 9 |
[GO] |
2024―Jan―31 |
SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences |
Xinling Wang, Lu Lu, Shibo Jiang |
| 10 |
[GO] |
2023―Dec―24 |
Double-take: SARS-CoV-2 has evolved to evade human innate immunity, twice |
Ellen F. Foxman |
| 11 |
[GO] |
2023―Oct―05 |
Monoclonal antibodies lock down SARS-CoV-2 spike |
Hsiang-Chi Huang, Davide Angeletti |
| 12 |
[GO] |
2023―Sep―11 |
Over but not gone: lingering epigenetic effects of COVID-19 |
Brandon T. Tran, Ruoqiong Cao, Katherine Y. King |
| 13 |
[GO] |
2023―Sep―09 |
HLA alleles: important pieces to the COVID-19 puzzle |
Patricia Castro-Santos, Ángel Carracedo, Roberto Díaz-Peña |
| 14 |
[GO] |
2023―Apr―06 |
Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis |
Cosima T. Baldari, Anna Onnis, Emanuele Andreano, Giuseppe Del Giudice, Rino Rappuoli |
| 15 |
[GO] |
2023―Mar―29 |
High-throughput screening of mutations affecting SARS-CoV-2 spike functions |
Shuai Xia, Zezhong Liu, Shibo Jiang |
| 16 |
[GO] |
2023―Jan―11 |
COVID-19 VACCINES AND A PERSPECTIVE ON AFRICA |
Alberto Mantovani, Maria Rescigno, Guido Forni, Francesca Tognon, Giovanni Putoto, Jerry Ictho, Peter Lochoro |
| 17 |
[GO] |
2022―Dec―22 |
Spiking SARS-CoV-2 anti-viral immunity in the respiratory tract |
Aaron Silva-Sanchez, Troy D. Randall |
| 18 |
[GO] |
2022―May―07 |
Insights into how SARS-CoV2 infection induces cytokine storms |
Kevin John Selva, Amy W. Chung |
| 19 |
[GO] |
2022―Feb―28 |
SARS-CoV-2 Vaccination Washes Away Original Antigenic Sin |
Shiv Pillai |
| 20 |
[GO] |
2022―Feb―11 |
NAD+ in COVID-19 and Viral Infections |
Minyan Zheng, Michael B. Schultz, David A. Sinclair |
| 21 |
[GO] |
2022―Jan―14 |
Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern |
Shan Su, Weihua Li, Shibo Jiang |
| 22 |
[GO] |
2021―Dec―07 |
Natural resistance against infections: focus on COVID-19 |
Mihai G. Netea, Jorge Domínguez-Andrés, Frank L. van de Veerdonk, Reinout van Crevel, Bali Pulendran, Jos W.M. van der Meer |
| 23 |
[GO] |
2021―Nov―19 |
Apart, together: coping with the COVID-19 pandemic |
Catarina Sacristán |
| 24 |
[GO] |
2021―Oct―19 |
Clash of the titans: interferons and SARS-CoV-2 |
Nolwenn Jouvenet, Caroline Goujon, Arinjay Banerjee |
| 25 |
[GO] |
2021―Sep―15 |
Immune imprinting and SARS-CoV-2 vaccine design |
Adam K. Wheatley, Annette Fox, Hyon-Xhi Tan, Jennifer A. Juno, Miles P. Davenport, Kanta Subbarao, Stephen J. Kent |
| 26 |
[GO] |
2021―Jul―12 |
Why are there so few (or so many) circulating coronaviruses? |
Benjamin L. Rice, Daniel C. Douek, Adrian B. McDermott, Bryan T. Grenfell, C. Jessica E. Metcalf |
| 27 |
[GO] |
2021―Feb―15 |
The dual nature of type-I interferons in SARS-CoV-2 induced inflammation |
Cecile King, Jonathan Sprent |
| 28 |
[GO] |
2020―Dec―24 |
The Immunologists’ Guide to Pandemic Preparedness |
Daniela Marín-Hernández, Nathaniel Hupert, Douglas F. Nixon |
| 29 |
[GO] |
2020―Dec―13 |
Complement factors in COVID-19 therapeutics and vaccines |
Liriye Kurtovic, James G. Beeson |
| 30 |
[GO] |
2020―Nov―13 |
Combining Antivirals and Immunomodulators to Fight COVID-19 |
Vincent Feuillet, Bruno Canard, Alain Trautmann |
| 31 |
[GO] |
2020―Nov―13 |
T Cells: Warriors of SARS-CoV-2 Infection |
Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Giuseppe Matarese |
| 32 |
[GO] |
2020―Nov―02 |
A Potential Role of Interleukin-10 in COVID-19 Pathogenesis |
Ligong Lu, Hui Zhang, Danielle J. Dauphars, You-Wen He |
| 33 |
[GO] |
2020―Oct―15 |
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines |
SangJoon Lee, Rudragouda Channappanavar, Thirumala-Devi Kanneganti |
| 34 |
[GO] |
2020―Oct―14 |
Mechanisms of SARS-CoV-2 transmission and pathogenesis |
Andrew G. Harrison, Tao Lin, Penghua Wang |
| 35 |
[GO] |
2020―Sep―23 |
The complement C5a-C5aR1 GPCR axis in COVID-19 therapeutics |
Trent M. Woodruff, Arun K. Shukla |
| 36 |
[GO] |
2020―Sep―17 |
Structural basis of SARS-CoV-2 and SARS-CoV-antibody interactions |
Edem Gavor, Yeu Khai Choong, Shi Yin Er, Hariharan Sivaraman, J. Sivaraman |
| 37 |
[GO] |
2020―Aug―12 |
Is immunological memory a burden in times of COVID-19? |
Enrique Ortega |
| 38 |
[GO] |
2020―Aug―11 |
Effect of low-pathogenic human coronavirus-specific antibodies on SARS-CoV-2 |
Shibo Jiang, Lanying Du |
| 39 |
[GO] |
2020―Aug―10 |
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis |
Alain Calender, Dominique Israel-Biet, Dominique Valeyre, Yves Pacheco |
| 40 |
[GO] |
2020―Aug―08 |
Does Cross-Neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses? |
Zhongren Ma, Pengfei Li, Aqsa Ikram, Qiuwei Pan |
| 41 |
[GO] |
2020―Jun―29 |
Using Serology with Models to clarify the trajectory of the SARS-CoV-2 emerging outbreak |
C. Jessica E. Metcalf, Cecile Viboud, David Spiro, Bryan T. Grenfell |
| 42 |
[GO] |
2020―Apr―24 |
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses |
Shibo Jiang, Christopher Hillyer, Lanying Du |
| 43 |
[GO] |
2020―Apr―11 |
Persistence of memory in times of COVID-19 |
Ger Rijkers |
| 44 |
[GO] |
2020―Apr―02 |
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses |
Shibo Jiang, Christopher Hillyer, Lanying Du |
| 45 |
[GO] |
2020―Mar―12 |
SARS Coronavirus Redux |
Enya Qing, Tom Gallagher |
